Life Sciences R&D Credits: The Overlooked Timing Rules That Affect Your Claim
Life sciences companies often experience rapid growth in research expenditures as they move from discovery and preclinical activities into clinical development, manufacturing scale-up and commercialization. As these costs increase, so does the importance of properly accounting for qualified research expenses (QREs) for purposes of the federal and state-level Research & Development (R&D) tax credit. One…




